Results 71 to 80 of about 29,746 (162)

Cost-Effectiveness Analysis of Bimekizumab against Interleukin-23 Inhibitors in Patients with Plaque Psoriasis in Japan. [PDF]

Dermatol Ther (Heidelb)
Igarashi A, Shiraishi K, Saito S, Kudo T, Iizuka Y, Yamamura E, Hase M.   +6 more
europepmc   +1 more source

The cost-effectiveness of inventory reserves for preventing drug shortages in Germany: a health-economic evaluation. [PDF]

Sci Rep
Gandjour A.
europepmc   +1 more source

Cost-effectiveness of inclisiran in patients with atherosclerotic cardiovascular disease from Chinese healthcare perspective. [PDF]

PLoS One
Liu M, Zhang X, Feng M, He Q, Feng Z.
europepmc   +1 more source

Cost-Effectiveness of Sodium-Glucose Co-Transporter-2 Inhibitors and Angiotensin Receptor-Neprilysin Inhibitors by Ejection Fraction and Drug Pricing in the United States: A Systematic Review. [PDF]

Circ Popul Health Outcomes
Alfie TJ, Wasfy JH, Kazi DS, Januzzi JL, Bellows BK, Cohen LP.   +5 more
europepmc   +1 more source

Cost-utility analysis of add-on ezetimibe to moderate-intensity statin versus moderate-intensity statin alone for secondary prevention in patients with acute coronary syndrome intolerant to high-intensity statin therapy in Thailand. [PDF]

Front Pharmacol
Promchit N, Chinwong S, Permsuwan U.
europepmc   +1 more source

Health-related quality of life and lifetime QALY loss among Indigenous Australians with chronic conditions: an age-stratified analysis. [PDF]

Qual Life Res
Haque R, Luebbe A, McGrail M, Nasir BF, Alam K, Wallis K, Leedie F, Kondalsamy-Chennakesavan S.   +7 more
europepmc   +1 more source

Cognitive Behavioral Therapy in Early Intervention for Psychosis: A Cost-Effectiveness Analysis. [PDF]

J Health Econ Outcomes Res
Duckworth M, Venturini S, Roman-Urrestarazu A.   +2 more
europepmc   +1 more source

Risk-based selection for carotid revascularisation using the IMPROVE score versus standard care in symptomatic carotid artery disease: a model-based cost-effectiveness analysis using pooled-data. [PDF]

BMJ Open
Nies KPH, Ramaekers B, Bierens J, Auer DP, Schindler A, Saam T, Bos D, de Jong PA, Nederkoorn PJ, de Borst GJ, van Oostenbrugge RJ, Joore MA, Kooi ME, Smits LJM.   +13 more
europepmc   +1 more source

Cost Analysis of Scleral Buckle and Pars Plana Vitrectomy for Retinal Detachment Surgery

Clinical Ophthalmology
Álvaro J Rallo-López,1 Rafael Martínez-Costa Pérez2 1Department of Ophthalmology, Clínica Baviera, Valencia, Spain; 2Department of Ophthalmology – Retina and Vitreous, Hospital Universitario y Politécnico La Fe, Valencia, SpainCorrespondence: Álvaro J ...
Rallo-López ÁJ, Martínez-Costa Pérez R   +1 more
doaj  

Quantifying the case for prevention: disease burden and cost-effective interventions in UK. [PDF]

J Public Health (Oxf)
Owen L, Taylor M.
europepmc   +1 more source